Cargando…
Enhanced Therapeutic Efficacy of iRGD-Conjugated Crosslinked Multilayer Liposomes for Drug Delivery
Targeting nanoparticles by conjugating various specific ligands has shown potential therapeutic efficacy in nanomedicine. However, poor penetration of antitumor drugs into solid tumors remains a major obstacle. Here, we describe a targeting strategy for antitumor drug delivery by conjugating a cross...
Autores principales: | Liu, Yarong, Ji, Man, Wong, Michael K., Joo, Kye-Il, Wang, Pin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652104/ https://www.ncbi.nlm.nih.gov/pubmed/23691500 http://dx.doi.org/10.1155/2013/378380 |
Ejemplares similares
-
iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome
por: Pooladanda, Venkatesh, et al.
Publicado: (2021) -
An iRGD peptide conjugated heparin nanocarrier for gastric cancer therapy
por: Ai, Shichao, et al.
Publicado: (2018) -
Codelivery of Chemotherapeutics via Crosslinked Multilamellar Liposomal Vesicles to Overcome Multidrug Resistance in Tumor
por: Liu, Yarong, et al.
Publicado: (2014) -
The Antitumour Activity of a Curcumin and Piperine Loaded iRGD-Modified Liposome: In Vitro and In Vivo Evaluation
por: Wang, Yingzheng, et al.
Publicado: (2023) -
iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery
por: Kang, Sujin, et al.
Publicado: (2020)